Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Ian Roberts a Cochrane Injuries Group, Public Health Intervention
Research Unit, London School of Hygiene and Tropical Medicine, London
WC1B 3DP, b Accident and Emergency Department, Leicester Royal Infirmary,
University Hospitals of Leicester NHS Trust, Leicester LE1 5WW Correspondence to: I Roberts Ian.Roberts{at}lshtm.ac.uk
Animal models are often used to test the effectiveness of a
drug or procedure before proceeding to clinical trials. One reason for
use of animal models is that they allow researchers to focus on
particular pathological processes without the confounding effects of
other injuries and treatments. However, it is essential that their
results are valid and precise. Biased or imprecise results from animal
experiments may result in clinical trials of biologically inert or even
harmful substances, thus exposing patients to unnecessary risk and
wasting scarce research resources. Moreover, if animal experiments fail
to inform medical research then the animals suffer unnecessarily.
The Italian pathologist Pietro Croce criticised vivisection on
scientific grounds. He argued that results from animal experiments cannot be applied to humans because of the biological differences between animals and humans and because the results of animal
experiments are too dependent on the type of animal model
used.1 Croce's arguments were based on insights
into zoology and pathophysiology. In this paper, we make some
methodological observations on animal experiments. Our observations
were made in the context of a systematic review of all available
randomised controlled trials of fluid resuscitation in animal models of
uncontrolled bleeding. We conducted this review because we wanted to
assess the scientific basis for fluid resuscitation. A previous
systematic review of randomised trials of fluid resuscitation in
bleeding trauma patients had provided no evidence that fluid
resuscitation improved outcome.2
We did a systematic review of randomised controlled trials of the
timing or volume of fluid administration in animal models of
uncontrolled haemorrhage. Details of the review methods, search strategy, and included trials are available on bmj.com. The combined electronic search strategies identified 3193 potentially eligible reports. Two reviewers examined each of these records and 104 reports
were retrieved in full. From these, we identified 44 randomised controlled trials meeting the inclusion criteria. The 44 trials included a total of 2039 experimental animals (1772 rats, 251 pigs, and
16 sheep). Mortality data were reported in 42 trials, of which 31 were
in rats, 10 in pigs, and one in sheep. In most of the rat experiments
uncontrolled bleeding was induced by resecting the tail. Three trials
in large animals (pigs and sheep) could not be included in the
meta-analysis because they did not include a no fluid resuscitation
group: one compared early and late resuscitation and two compared
different blood pressure resuscitation targets. Three trials in rats
could not be included in the meta-analysis: one compared early and late
fluid resuscitation, one compared different blood pressure
resuscitation targets, and one presented time to death data only.
The pooled odds ratio (fixed effect) for death in large animals (pigs
and sheep) with fluid resuscitation was 0.63 (95% confidence interval
0.15 to 2.61) but there was statistical heterogeneity ( In clinical trials, systematic error can arise from problems
with the study design, especially if allocation of treatment is
inadequately concealed.18 Bias is
avoided by ensuring strict randomisation with well concealed treatment
allocation. The extent to which inadequate concealment of allocation
might introduce bias in animal experiments is uncertain. However, it is
easy to imagine how bias could arise. For example, weaker animals
may be easier to catch than healthy animals, and this could result in
systematic differences between the intervention and control groups on
baseline prognostic factors. Of the 44 randomised controlled trials
meeting the inclusion criteria, only two described how the animals were
divided into treatment groups; both of these trials used alternation.
Random error in clinical trials is minimised by increasing the number
of randomised participants.19 However, animal researchers are encouraged to reduce the number of experimental animals to a
minimum. Indeed, the need to use the minimum number of animals to
obtain valid results is embodied in the Animals (Scientific Procedures) Act 1986 and European legislation.20 As a
result, some animal experiments are underpowered and provide little
reliable information. All of the animal experiments in our systematic
review were small (fig 2). The average number of animals per trial was 46 (2039/44), and the largest trial included only 207 animals (rats). None of the trials would have been large enough to detect reliably a 10% absolute difference (halving) in the risk of death between the intervention and comparison groups. Moreover, many of the
trials included several different fluid resuscitation groups, which we
combined for our analyses. The average number of experimental animals
per treatment group was only 13 (160 groups). If, as was the case in
most trials, the aim was to compare the effects of different fluid
resuscitation regimens, the studies had little power.
Although each individual animal experiment provides little
reliable information on the effectiveness of fluid resuscitation, each
contributes to the total body of evidence. Any inferences should be
based on all the evidence.21 A 1996 narrative review of fluid resuscitation in animal experiments included
only nine of the 24 trials (38%) that were available at that
time.22
Systematic reviews and meta-analyses of animal experiments are
uncommon. About 1 in 1000 Medline records pertaining to human research
is tagged as a meta-analysis compared with 1 in 10 000 records
pertaining to animal research. In his book The Principles of
Humane Experimental Technique, William Russell proposed the principle of reduction Publication bias may be as potent a threat to validity in systematic
reviews of animal experiments as it is in systematic reviews of
clinical trials. We contacted the authors of included trials to ask
about unpublished studies but none were identified. However, it would
be surprising if there were no unpublished trials meeting our inclusion
criteria. Prospective registration of animal experiments at inception
may help to avoid the problem of publication bias.24 In the United Kingdom, the
Animals (Scientific Procedures) Act 1986 regulates "any experimental
or other scientific procedure applied to a protected animal which may
have the effect of causing that animal pain, suffering, distress, or
lasting harm." Researchers must have a project licence from the Home
Office before conducting any animal research, and the licence
application describes the experimental protocol. These data could be
used for prospective registration of all animal experiments.
Systematic reviews of animal models could, like ours, include a range
of animal species and models. If the results were consistent across
species and models this would indicate that they might also apply in
humans. Since the primary aim of animal experimentation is to inform
human experimentation, this would be valuable information.
We found substantial statistical heterogeneity in our meta-analysis,
making it impossible to interpret the odds ratios. Investigation of
heterogeneity is essential and can increase the scientific and clinical
relevance of their results. In our meta-analysis, stratification
according to how uncontrolled bleeding was induced accounted for a
large amount of the heterogeneity, but these results need to be
interpreted with caution. Meta-analytic subgroup analyses are akin to
subgroup analyses within trials and are prone to bias. Although we
specified in our protocol that the analyses would be stratified
according to the animal model used, we did not specify that we would
stratify according to where the tail was cut. Nevertheless, the
meta-analysis provides an insight into model dependency that could be
taken into account in future animal experiments and when considering
whether the results can be generalised to humans.
Animal experiments can inform human health care only if their
results are valid and can be generalised. However, little information is available on the methodological determinants of bias in animal experiments, and in our example the sample sizes were too small to
obtain precise estimates of the effects of the interventions. Systematic reviews of animal experiments would help to ensure that
animal experiments do not set out to answer questions that have already
been answered, reduce bias and increase precision, and provide
reassurance about whether the results can be generalised. Prospective
registration of animal experiments would help to avoid publication
bias. In a recent editorial, Smith promoted the three Rs of animal
research first suggested by William Russell: replacement, reduction,
and refinement.25 On methodological grounds, animal experimentation would better contribute to human health care if we
promoted registration, randomisation, and systematic reviews.
Summary points
New drugs and procedures are usually tested in animals before
conducting clinical trials
Validity of animal experiments is essential for human health care and
fundamental to animal welfare
A systematic review of animal experiments on fluid resuscitation found
that most studies were underpowered and provided little information on
possible bias
Systematic reviews of animal experiments allow a more objective
appraisal of the evidence and reduce the chance of false negatives
results
Systematic reviews across species would help determine whether the
results could be generalised to humans
![]()
Systematic review of fluid resuscitation in uncontrolled
haemorrhage
2
=16.84, df=7, P=0.018). The pooled odds ratio (fixed effect) for death in small animals with fluid resuscitation was 1.14 (0.65 to
2.02). Again, there was substantial heterogeneity (
2
=93.40, df=27, P<0.0001). When the meta-analysis was stratified according to how uncontrolled bleeding was induced, a large amount of
the heterogeneity was accounted for. Figure 1 shows the results of
meta-analysis of the 16 randomised controlled trials of fluid resuscitation in rats in which bleeding was induced by resecting the
tail. The meta-analysis is stratified according to where the tail was
cut. Fluid resuscitation seems to be harmful (odds ratio=2.88, 95%
confidence interval 1.72 to 4.80) with less than 50% tail resection
(
2 =5.57, df=7, P=0.59) but beneficial (odds ratio=0.25,
0.15 to 0.42) with greater than 50% tail resection (
2
=6.14, df=7, P=0.52).

View larger version (34K):
[in a new window]
Fig 1.
Meta-analysis of 16 randomised controlled
trials of fluid resuscitation in rats with uncontrolled haemorrhage by
tail resection. *Capone11 reported two trials
![]()
Are the individual experiments valid?

View larger version (28K):
[in a new window]
Fig 2.
Trial size and smallest absolute risk reduction
detectable
![]()
Has all the evidence been assessed?
that is, the use of methods to "reduce the
number of animals needed to obtain information of a given amount and
precision."23 Meta-analyses of the results of previous animal experiments would increase the precision of estimates of treatment effects and therefore reduce the number of animals needed in
future experiments.
![]()
Implications for human health
| |
Acknowledgments |
|---|
We thank Sir Iain Chalmers for his comments on the manuscript and the authors of the included trials who responded to our requests for further information.
Contributors: IR and PE proposed the study. IR drafted the protocol that was revised following comments from all authors. IR and SH examined the electronic search results for reports of possibly relevant randomised controlled trials. IR, PE, and SH applied the selection criteria independently to the trial reports. IR and IK extracted information from the included trials. IK contacted authors for further information and IK and IR conducted the analyses. IR drafted the paper that was revised on the basis of comments from IK, PE, SH. IR will act as guarantor.
| |
Footnotes |
|---|
Funding: None.
Competing interests: None declared.
The methods of the systematic
review and details of included trials appear on bmj.com
| |
References |
|---|
| 1. | Croce P. Vivisection or science? An investigation into testing drugs and safeguarding health. London: Zed Books, 1999. |
| 2. | Roberts I, Evans A, Bunn F, Kwan I, Crowhurst E. Normalising the blood pressure in bleeding trauma patients may be harmful. Lancet 2001; 357: 385-387[CrossRef][ISI][Medline]. |
| 3. | Bilynskyj MC, Errington ML, Velasco IT, Silva R. Effect of hypertonic sodium chloride (7.5%) on uncontrolled hemorrhage in rats and its interaction with different anesthetic procedures. Circulatory Shock 1992; 36: 68-73[Medline]. |
| 4. | Gross D, Landau EH, Klin B, Krausz MM. Quantitative measurement of bleeding following hypertonic saline therapy in `uncontrolled' hemorrhagic shock. J Trauma 1989; 29: 79-83[Medline]. |
| 5. | Krausz MM, Kablan M, Rabinovici R, Klin B, Sherman Y, Gross D. Effect of injured vessel size on bleeding following hypertonic saline infusion in uncontrolled hemorrhagic shock in anesthetised rats. Circulatory Shock 1991; 35: 9-13[Medline]. |
| 6. | Krausz MM, Horn Y, Gross D. The combined effect of small volume hypertonic saline and normal saline solutions in uncontrolled hemorrhagic shock. Surg Gynecol Obstet 1992; 174: 363-368[Medline]. |
| 7. | Krausz MM, Landau EH, Klin B, Gross D. Hypertonic saline treatment of uncontrolled hemorrhagic shock at different periods from bleeding. Arch Surg 1992; 127: 93-96[Abstract]. |
| 8. | Krausz MM, Bar-Ziv M, Rabinovici R, Gross D. "Scoop and run" or stabilize hemorrhagic shock with normal saline or small-volume hypertonic saline? J Trauma 1992; 33: 6-10[Medline]. |
| 9. | Rabinovici R, Gross D, Krausz MM. Infusion of small volume of 7.5 per cent sodium chloride in 6.0 per cent dextran 70 for the treatment of uncontrolled hemorrhagic shock. Surg Gynecol Obstet 1989; 169: 137-142[Medline]. |
| 10. |
Talmor D, Merkind V, Artru AA, Shapiro O, Geva D, Roytblat L, et al.
Treatment to support blood pressure increases bleeding and/or decreases survival in a rat model of closed head trauma combined with uncontrolled hemorrhage.
Anesth Analg
1999;
89:
950-956 |
| 11. | Capone AC, Safar P, Stezoski W, Tisherman S, Peitzman AB. Improved outcome with fluid restriction in treatment of uncontrolled hemorrhagic shock. J Am Coll Surg 1995; 180: 49-56[Medline]. |
| 12. | Capone AC, Safar P, Stezoski SW, Peitzman A, Tisherman S. Uncontrolled hemorrhagic shock outcome model in rats. Resuscitation 1995; 29: 143-152[CrossRef][ISI][Medline]. |
| 13. | Greene SP, Soucy DM, Song WC, Barber AE, Hagedorn FN, Illner HP, et al. Early isotonic saline resuscitation from uncontrolled hemorrhage in rats. Surgery 1998; 124: 568-574[ISI][Medline]. |
| 14. | Kim S, Stezoski SW, Safar P, Capone A, Tisherman S. Hypothermia and minimal fluid resuscitation increases survival after uncontrolled hemorrhagic shock in rats. J Trauma 1997; 42: 213-222[ISI][Medline]. |
| 15. | Sindlinger JF, Soucy DM, Greene SP, Barber AE, Illner H, Shires GT. The effects of isotonic saline volume resuscitation in uncontrolled hemorrhage. Surg Gynecol Obstet 1993; 177: 545-550[ISI][Medline]. |
| 16. | Soucy DM, Rudé, Hsia WC, Hagedorn FN, Illner H, Shires GT. The effects of varying fluid volume and rate of resuscitation during uncontrolled hemorrhage. J Trauma 1999; 46: 209-214[ISI][Medline]. |
| 17. | Soucy DM, Sindlinger JF, Greene SP, Barber AE, Illner HP, Shires GT. Isotonic saline resuscitation in uncontrolled hemorrhage under various anesthetic conditions. Ann Surg 1995; 222: 89-93. |
| 18. | Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412[Abstract]. |
| 19. | Peto R, Collins R, Gray R. Large-scale randomised evidence: large simple trials and overviews of trials. J Clin Epidemiol 1995; 48: 23-40[CrossRef][ISI][Medline]. |
| 20. | Guidance on the operation of the Animals (Scientific Procedures) Act 1986. www.homeoffice.gov.uk/animact/aspag1.htm (accessed August 2001). |
| 21. | Chalmers I. Using systematic reviews and registers of on-going trials for scientific and ethical trial design, monitoring, and reporting. In: Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in healthcare: meta-analyses in context. London: BMJ Books, 2001:429-443. |
| 22. | Dries DJ. Hypotensive resuscitation. Shock 1996; 6: 311-316[ISI][Medline]. |
| 23. | Russell WMS, Burch RL. The principles of humane experimental technique. London: Methuen, 1959. |
| 24. | Horton R, Smith R. Time to register randomised trials. Lancet 1999; 354: 1138-1139[CrossRef][ISI][Medline]. |
| 25. |
Smith R.
Animal research: the need for a middle ground.
BMJ
2001;
322:
248-249 |
(Accepted 14 August 2001)
Read all Rapid Responses